Consensus statement on the management of urticaria

Area of Science:

• Dermatology
• Allergology
• Immunology

Background:

• Urticaria is a complex skin condition with diverse presentations, making diagnosis difficult.
• Current diagnostic methods for urticaria are often non-specific and costly, complicating management.
• Chronic urticaria significantly impacts patients' quality of life, necessitating effective therapeutic strategies.

Purpose of the Study:

• To provide a comprehensive guideline on the definition, causes, classification, and management of urticaria.
• To outline evidence-based treatment approaches for urticaria, focusing on patient outcomes.
• To offer practical recommendations for clinicians managing patients with urticaria.

Main Methods:

• Development of a consensus statement by the Special Interest Group - Urticaria (IADVL).
• Review and synthesis of current knowledge on urticaria diagnosis and treatment.
• Formulation of recommendations based on expert consensus and available evidence.

Main Results:

• Urticaria management involves identifying and eliminating triggers alongside symptomatic treatment.
• Second-generation non-sedating H1 antihistamines are recommended as the first-line therapy.
• Dosage titration of antihistamines up to four times the standard dose is advised for non-responders.

Conclusions:

• Effective urticaria management requires a multi-faceted approach, including trigger identification and pharmacotherapy.
• H1 antihistamines provide a cost-effective and generally safe treatment option for urticaria.
• Alternative treatment strategies should be considered for patients refractory to standard antihistamine therapy, considering cost-effectiveness.